Coping with chronic pain, depression, and high blood pressure
Can you prevent the hunched back of kyphosis?
What is ventricular bigeminy?
Emojis in electronic health records could be confusing
Doing different types of exercise linked to a longer life
CPR on TV may be misleading
How gum disease may raise heart disease risk
FDA approves nasal spray to treat rapid heart rhythm
Smart watch may improve detection of atrial fibrillation
4 keys to a heart-healthy diet
Guru P. Sonpavde, MD
Contributor
Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.
Posts by Guru P. Sonpavde, MD
Guru P. Sonpavde, MD
Cancer treatment: Is a clinical trial right for you?
Healthy aging and longevity
Immunotherapy: What you need to know
Coping with chronic pain, depression, and high blood pressure
Can you prevent the hunched back of kyphosis?
What is ventricular bigeminy?
Emojis in electronic health records could be confusing
Doing different types of exercise linked to a longer life
CPR on TV may be misleading
How gum disease may raise heart disease risk
FDA approves nasal spray to treat rapid heart rhythm
Smart watch may improve detection of atrial fibrillation
4 keys to a heart-healthy diet
